Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Open accessThe DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Abstract
Atherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most deaths in westernized societies with numbers increasing at a marked rate in developing countries. The disease is initiated by the activation of the endothelium by various risk factors leading to chemokine-mediated recruitment of immune cells. The uptake of modified lipoproteins by macrophages along with defective cholesterol efflux gives rise to foam cells associated with the fatty streak in the early phase of the disease. As the disease progresses, complex fibrotic plaques are produced as a result of lysis of foam cells, migration and proliferation of vascular smooth muscle cells and continued inflammatory response. Such plaques are stabilized by the extracellular matrix produced by smooth muscle cells and destabilized by matrix metalloproteinase from macrophages. Rupture of unstable plaques and subsequent thrombosis leads to clinical complications such as myocardial infarction. Cytokines are involved in all stages of atherosclerosis and have a profound influence on the pathogenesis of this disease. This review will describe our current understanding of the roles of different cytokines in atherosclerosis together with therapeutic approaches aimed at manipulating their actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Ley, K., Laudanna, C., Cybulsky, M. I., & Nourshargh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2156 · Cited by 4,354 · cited 6×
“The capture and rolling phase for Lys6C monocytes involves immobilization of CCL5 and CXCL1 on proteoglycans and P-selectins on ECs [14–16].”
BackgroundInfluentialNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Macrophages in atherosclerosis: a dynamic balance
Moore, K. J., Sheedy, F. J., & Fisher, E. A. (2013) · Nature reviews. Immunology · doi:10.1038/nri3520 · Cited by 2,559 · cited 11×
“Defective clearance of such apoptotic cells (efferocytosis) continues to result in lipid accumulation in the atherosclerotic lesions [2,14].”
BackgroundInfluentialMechanisms of plaque formation and rupture
Bentzon, J. F., Otsuka, F., Virmani, R., & Falk, E. (2014) · Circulation Research · doi:10.1161/circresaha.114.302721 · Cited by 2,391 · cited 17×
“SMCs also play an important role in atherosclerosis and more advanced lesions are generally covered with a fibrous cap, composed of SMCs and ECM components produced by them, and lipid-rich necrotic core [2].”
BackgroundInfluentialAtherosclerosis: current pathogenesis and therapeutic options
Weber, C., & Noels, H. (2011) · Nature Medicine · doi:10.1038/nm.2538 · Cited by 2,203
Evolving functions of endothelial cells in inflammation
Pober, J. S., & Sessa, W. C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2171 · Cited by 2,022
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Gu, L., Okada, Y., Clinton, S. K., Gerard, C., Sukhova, G. K., Libby, P., & Rollins, B. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80139-2 · Cited by 1,575
Stewart, C. R., Stuart, L. M., Wilkinson, K., van Gils, J. M., Deng, J., Halle, A., Rayner, K. J., Boyer, L., Zhong, R., Frazier, W. A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1836 · Cited by 1,513 · cited 1×
“Moreover, OxLDL uptake by CD36 causes expression of cytokines via a mechanism involving TLR2-TLR4 [225].”
BackgroundWriting Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182456d46 · Cited by 1,512
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000442015.53336.12 · Cited by 1,408
Tacke, F., Alvarez, D., Kaplan, T. J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28549 · Cited by 1,323 · cited 2×
“Overall, the three most prominent chemokine:chemokine receptors involved in the transmigration of Ly6Chigh monocytes include CCL2:CCR2, CX3CL1:CX3CR1, and CCL5-CCR5 [14,73].”
BackgroundBernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Boring, L., Gosling, J., Chensue, S. W., Kunkel, S. L., Farese, R. V., Broxmeyer, H. E., & Charo, I. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119798 · Cited by 1,096
Local proliferation dominates lesional macrophage accumulation in atherosclerosis
Robbins, C. S., Hilgendorf, I., Weber, G. F., Theurl, I., Iwamoto, Y., Figueiredo, J.-L., Gorbatov, R., Sukhova, G. K., Gerhardt, L. M. S., Smyth, D., et al. (2013) · Nature Medicine · doi:10.1038/nm.3258 · Cited by 1,041 · cited 1×
“In addition, local proliferation dominates macrophage accumulation in atherosclerotic plaques [197].”
BackgroundSheedy, F. J., Grebe, A., Rayner, K. J., Kalantari, P., Ramkhelawon, B., Carpenter, S. B., Becker, C. E., Ediriweera, H. N., Mullick, A. E., Golenbock, D. T., et al. (2013) · Nature Immunology · doi:10.1038/ni.2639 · Cited by 935
Monocytes in atherosclerosis: subsets and functions
Woollard, K. J., & Geissmann, F. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.228 · Cited by 890
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.
Gupta, S., Pablo, A. M., Jiang, X. C., Wang, N., Tall, A. R., & Schindler, C. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119465 · Cited by 868
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748 · cited 1×
“[85–91]”
Smith, J. D., Trogan, E., Ginsberg, M., Grigaux, C., Tian, J., & Miyata, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8264 · Cited by 724
Immune Effector Mechanisms Implicated in Atherosclerosis: From Mice to Humans
Libby, P., Lichtman, A. H., & Hansson, G. K. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.009 · Cited by 671
Combadière, C., Potteaux, S., Rodero, M., Simon, T., Pezard, A., Esposito, B., Merval, R., Proudfoot, A., Tedgui, A., & Mallat, Z. (2008) · Circulation · doi:10.1161/circulationaha.107.745091 · Cited by 663
Macrophage subsets in atherosclerosis
Chinetti-Gbaguidi, G., Colin, S., & Staels, B. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.173 · Cited by 646
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
Animal Models of Atherosclerosis
Getz, G. S., & Reardon, C. A. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.237693 · Cited by 630
Amento, E. P., Ehsani, N., Palmer, H., & Libby, P. (1991) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1223 · Cited by 609
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Kleemann, R., Zadelaar, S., & Kooistra, T. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn120 · Cited by 606
Recent Advances on the Role of Cytokines in Atherosclerosis
Ait-Oufella, H., Taleb, S., Mallat, Z., & Tedgui, A. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.207415 · Cited by 578
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Mouse Models for Atherosclerosis and Pharmaceutical Modifiers
Zadelaar, S., Kleemann, R., Verschuren, L., de Vries-Van der Weij, J., van der Hoorn, J., Princen, H. M., & Kooistra, T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.142570 · Cited by 527
Newby, A. C. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.173898 · Cited by 496
Inhibition of Tumor Necrosis Factor-α Reduces Atherosclerosis in Apolipoprotein E Knockout Mice
Brånén, L., Hovgaard, L., Nitulescu, M., Bengtsson, E., Nilsson, J., & Jovinge, S. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000143933.20616.1b · Cited by 495
Mallat, Z., Gojova, A., Marchiol-Fournigault, C., Esposito, B., Kamaté, C., Merval, R., Fradelizi, D., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh2201.099415 · Cited by 490
Decreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesis
Lesnik, P., Haskell, C. A., & Charo, I. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15555 · Cited by 487 · cited 1×
“[69–72]”
Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout Mice
Combadière, C., Potteaux, S., Gao, J.-L., Esposito, B., Casanova, S., Lee, E. J., Debré, P., Tedgui, A., Murphy, P. M., & Mallat, Z. (2003) · Circulation · doi:10.1161/01.cir.0000057548.68243.42 · Cited by 476
Monocyte Chemoattractant Protein-1 Accelerates Atherosclerosis in Apolipoprotein E-Deficient Mice
Aiello, R. J., Bourassa, P.-A. K., Lindsey, S., Weng, W., Natoli, E., Rollins, B. J., & Milos, P. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.6.1518 · Cited by 466
Binder, C. J., Hartvigsen, K., Chang, M.-K., Miller, M., Broide, D., Palinski, W., Curtiss, L. K., Corr, M., & Witztum, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420479 · Cited by 452
Davenport, P., & Tipping, P. G. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63471-2 · Cited by 444
Interleukin-6 Exacerbates Early Atherosclerosis in Mice
Huber, S. A., Sakkinen, P., Conze, D., Hardin, N., & Tracy, R. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.10.2364 · Cited by 443
Disruption of TGF-β signaling in T cells accelerates atherosclerosis
Robertson, A.-K. L., Rudling, M., Zhou, X., Gorelik, L., Flavell, R. A., & Hansson, G. K. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18607 · Cited by 441
Bae, Y. S., Lee, J. H., Choi, S. H., Kim, S., Almazan, F., Witztum, J. L., & Miller, Y. I. (2009) · Circulation Research · doi:10.1161/circresaha.108.181040 · Cited by 427
Blockade of Interleukin-17A Results in Reduced Atherosclerosis in Apolipoprotein E–Deficient Mice
Smith, E., Prasad, K.-M. R., Butcher, M., Dobrian, A., Kolls, J. K., Ley, K., & Galkina, E. (2010) · Circulation · doi:10.1161/circulationaha.109.924886 · Cited by 421
Zernecke, A., Bot, I., Djalali-Talab, Y., Shagdarsuren, E., Bidzhekov, K., Meiler, S., Krohn, R., Schober, A., Sperandio, M., Soehnlein, O., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.160697 · Cited by 417
Micro RNA ‐146 represses endothelial activation by inhibiting pro‐inflammatory pathways
Cheng, H. S., Sivachandran, N., Lau, A., Boudreau, E., Zhao, J. L., Baltimore, D., Delgado‐Olguin, P., Cybulsky, M. I., & Fish, J. E. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202318 · Cited by 417
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Perez, N., Yasukawa, H., Van Snick, J., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090545 · Cited by 408
Mallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, Y., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh1901.098735 · Cited by 407
McLaren, J. E., Michael, D. R., Ashlin, T. G., & Ramji, D. P. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.04.002 · Cited by 397
Self-citationRole of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice.
Qiao, J. H., Tripathi, J., Mishra, N. K., Cai, Y., Tripathi, S., Wang, X. P., Imes, S., Fishbein, M. C., Clinton, S. K., Libby, P., et al. (1997) · Europe PMC (PubMed Central) · Cited by 396
Interleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Circulation Research · doi:10.1161/hh0202.105292 · Cited by 385
Anti-inflammatory therapies for atherosclerosis
Bäck, M., & Hansson, G. K. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.5 · Cited by 378
Exogenous Interferon-γ Enhances Atherosclerosis in Apolipoprotein E−/− Mice
Whitman, S. C., Ravisankar, P., Elam, H., & Daugherty, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64820-1 · Cited by 378
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 373
Everett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368 · cited 1×
“the secondary prevention of myocardial infarction [244].”
Inhibition of IL-17A Attenuates Atherosclerotic Lesion Development in ApoE-Deficient Mice
Erbel, C., Chen, L., Bea, F., Wangler, S., Celik, S., Lasitschka, F., Wang, Y., Böckler, D., Katus, H. A., & Dengler, T. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901126 · Cited by 358
Pinderski, L. J., Fischbein, M. P., Subbanagounder, G., Fishbein, M. C., Kubo, N., Cheroutre, H., Curtiss, L. K., Berliner, J. A., & Boisvert, W. A. (2002) · Circulation Research · doi:10.1161/01.res.0000018941.10726.fa · Cited by 356
Trogan, E., Feig, J. E., Dogan, S., Rothblat, G. H., Angeli, V., Tacke, F., Randolph, G. J., & Fisher, E. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511043103 · Cited by 346
Ohta, H., Wada, H., Niwa, T., Kirii, H., Iwamoto, N., Fujii, H., Saito, K., Sekikawa, K., & Seishima, M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.016 · Cited by 334
Caligiuri, G., Rudling, M., Ollivier, V., Jacob, M.-P., Michel, J.-B., Hansson, G. K., & Nicoletti, A. (2003) · Molecular Medicine · doi:10.1007/bf03402102 · Cited by 332
Inflammation-Induced Thrombosis: Mechanisms, Disease Associations and Management
Keser, G. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799504731 · Cited by 322
The impact of the inflammatory response on coagulation
Esmon, C. T. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.028 · Cited by 311
The Role of Interleukin 12 in the Development of Atherosclerosis in ApoE-Deficient Mice
Lee, T.-S., Yen, H.-C., Pan, C.-C., & Chau, L.-Y. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.734 · Cited by 311
Freigang, S., Ampenberger, F., Weiss, A., Kanneganti, T.-D., Iwakura, Y., Hersberger, M., & Kopf, M. (2013) · Nature Immunology · doi:10.1038/ni.2704 · Cited by 307
Cardilo‐Reis, L., Gruber, S., Schreier, S. M., Drechsler, M., Papac‐Milicevic, N., Weber, C., Wagner, O., Stangl, H., Soehnlein, O., & Binder, C. J. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201374 · Cited by 292 · cited 1×
“The pro-atherogenic roles of IFN-g and IL-1b are well established (Tables 3 and 4) and recent studies have shown that administration of IL-13 in the LDLr / model system drives M2 macrophage polarization and inhibits atherosclerosis progression [121].”
BackgroundMonocyte-Directed RNAi Targeting CCR2 Improves Infarct Healing in Atherosclerosis-Prone Mice
Majmudar, M. D., Keliher, E. J., Heidt, T., Leuschner, F., Truelove, J., Sena, B. F., Gorbatov, R., Iwamoto, Y., Dutta, P., Wojtkiewicz, G., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000116 · Cited by 292
Buono, C., Come, C. E., Stavrakis, G., Maguire, G. F., Connelly, P. W., & Lichtman, A. H. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000059419.11002.6e · Cited by 289
Impact of Interleukin-6 on Plaque Development and Morphology in Experimental Atherosclerosis
Schieffer, B., Selle, T., Hilfiker, A., Hilfiker-Kleiner, D., Grote, K., Tietge, U. J. F., Trautwein, C., Luchtefeld, M., Schmittkamp, C., Heeneman, S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000148135.08582.97 · Cited by 288
Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice
Braunersreuther, V., Zernecke, A., Arnaud, C., Liehn, E. A., Steffens, S., Shagdarsuren, E., Bidzhekov, K., Burger, F., Pelli, G., Luckow, B., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000253886.44609.ae · Cited by 288
Heller, E. A., Liu, E., Tager, A. M., Yuan, Q., Lin, A. Y., Ahluwalia, N., Jones, K., Koehn, S. L., Lok, V. M., Aikawa, E., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.605121 · Cited by 283
The Influence of Innate and Adaptive Immune Responses on Atherosclerosis
Witztum, J. L., & Lichtman, A. H. (2014) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163936 · Cited by 277
Weber, C., Meiler, S., Döring, Y., Koch, M., Drechsler, M., Megens, R. T. A., Rowinska, Z., Bidzhekov, K., Fecher, C., Ribechini, E., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44925 · Cited by 273
Inoue, S., Egashira, K., Ni, W., Kitamoto, S., Usui, M., Otani, K., Ishibashi, M., Hiasa, K.-I., Nishida, K.-I., & Takeshita, A. (2002) · Circulation · doi:10.1161/01.cir.0000038140.80105.ad · Cited by 256
Phenotypic Polarization of Macrophages in Atherosclerosis
Leitinger, N., & Schulman, I. G. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300173 · Cited by 256
Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice.
Rajavashisth, T., Qiao, J. H., Tripathi, S., Tripathi, J., Mishra, N., Hua, M., Wang, X. P., Loussararian, A., Clinton, S., Libby, P., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119891 · Cited by 247
Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
Schuett, H., Oestreich, R., Waetzig, G. H., Annema, W., Luchtefeld, M., Hillmer, A., Bavendiek, U., von Felden, J., Divchev, D., Kempf, T., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.229435 · Cited by 243
Wei, Y., Nazari-Jahantigh, M., Chan, L., Zhu, M., Heyll, K., Corbalán-Campos, J., Hartmann, P., Thiemann, A., Weber, C., & Schober, A. (2013) · Circulation · doi:10.1161/circulationaha.112.000736 · Cited by 234
Lipoprotein Accumulation in Macrophages via Toll-Like Receptor-4–Dependent Fluid Phase Uptake
Choi, S.-H., Harkewicz, R., Lee, J. H., Boullier, A., Almazan, F., Li, A. C., Witztum, J. L., Bae, Y. S., & Miller, Y. I. (2009) · Circulation Research · doi:10.1161/circresaha.108.192880 · Cited by 230
Saederup, N., Chan, L., Lira, S. A., & Charo, I. F. (2008) · Circulation · doi:10.1161/circulationaha.107.743872 · Cited by 228
Goossens, P., Gijbels, M. J. J., Zernecke, A., Eijgelaar, W., Vergouwe, M. N., van der Made, I., Vanderlocht, J., Beckers, L., Buurman, W. A., Daemen, M. J. A. P., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.008 · Cited by 225
Bhaskar, V., Yin, J., Mirza, A. M., Phan, D., Vanegas, S., Issafras, H., Michelson, K., Hunter, J. J., & Kantak, S. S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.026 · Cited by 225
The Acute Phase Response Is Associated with Retinoid X Receptor Repression in Rodent Liver
Beigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000953200 · Cited by 223
Gao, Q., Jiang, Y., Ma, T., Zhu, F., Gao, F., Zhang, P., Guo, C., Wang, Q., Wang, X., Ma, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000116 · Cited by 222
de Jager, S. C. A., Bermúdez, B., Bot, I., Koenen, R. R., Bot, M., Kavelaars, A., de Waard, V., Heijnen, C. J., Muriana, F. J. G., Weber, C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100370 · Cited by 222
Alexander, M. R., Moehle, C. W., Johnson, J. L., Yang, Z., Lee, J. K., Jackson, C. L., & Owens, G. K. (2012) · Journal of Clinical Investigation · doi:10.1172/jci43713 · Cited by 217
Madhur, M. S., Funt, S. A., Li, L., Vinh, A., Chen, W., Lob, H. E., Iwakura, Y., Blinder, Y., Rahman, A., Quyyumi, A. A., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.227629 · Cited by 212
Elhage, R., Maret, A., Pieraggi, M.-T., Thiers, J. C., Arnal, J. F., & Bayard, F. (1998) · Circulation · doi:10.1161/01.cir.97.3.242 · Cited by 209
Du, F., Yu, F., Wang, Y., Hui, Y., Carnevale, K., Fu, M., Lu, H., & Fan, D. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.302701 · Cited by 209
Soehnlein, O., Drechsler, M., Döring, Y., Lievens, D., Hartwig, H., Kemmerich, K., Ortega‐Gómez, A., Mandl, M., Vijayan, S., Projahn, D., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201717 · Cited by 205
Wuttge, D. M., Zhou, X., Sheikine, Y., Wågsäter, D., Stemme, V., Hedin, U., Stemme, S., Hansson, G. K., & Sirsjö, A. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000124102.11472.36 · Cited by 202
Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis
Ait-Oufella, H., Sage, A. P., Mallat, Z., & Tedgui, A. (2014) · Circulation Research · doi:10.1161/circresaha.114.302761 · Cited by 201
MERHISOUSSI, F., KWAK, B., MAGNE, D., CHADJICHRISTOS, C., BERTI, M., PELLI, G., JAMES, R., MACH, F., & GABAY, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.008 · Cited by 200
Chemokines in Atherosclerosis: Proceedings Resumed
Zernecke, A., & Weber, C. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301655 · Cited by 194
Gisterå, A., Robertson, A.-K. L., Andersson, J., Ketelhuth, D. F. J., Ovchinnikova, O., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006133 · Cited by 194
Teupser, D., Pavlides, S., Tan, M., Gutierrez-Ramos, J.-C., Kolbeck, R., & Breslow, J. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408096101 · Cited by 189
Boisvert, W. A., Rose, D. M., Johnson, K. A., Fuentes, M. E., Lira, S. A., Curtiss, L. K., & Terkeltaub, R. A. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.040748 · Cited by 188
Danzaki, K., Matsui, Y., Ikesue, M., Ohta, D., Ito, K., Kanayama, M., Kurotaki, D., Morimoto, J., Iwakura, Y., Yagita, H., et al. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.229997 · Cited by 187
Gilbert, J., Lekstrom-Himes, J., Donaldson, D., Lee, Y., Hu, M., Xu, J., Wyant, T., & Davidson, M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.11.005 · Cited by 185
IL-33 Reduces Macrophage Foam Cell Formation
McLaren, J. E., Michael, D. R., Salter, R. C., Ashlin, T. G., Calder, C. J., Miller, A. M., Liew, F. Y., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000520 · Cited by 184
Self-citationBlockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis
Hauer, A. D., Uyttenhove, C., de Vos, P., Stroobant, V., Renauld, J. C., van Berkel, T. J. C., van Snick, J., & Kuiper, J. (2005) · Circulation · doi:10.1161/circulationaha.104.533463 · Cited by 182
Targeted Disruption of the Scavenger Receptor and Chemokine CXCL16 Accelerates Atherosclerosis
Aslanian, A. M., & Charo, I. F. (2006) · Circulation · doi:10.1161/circulationaha.105.540583 · Cited by 177
IFN- γ Deficiency Exerts Gender-Specific Effects on Atherogenesis in Apolipoprotein E -/- Mice
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900260100141 · Cited by 176
Tsimikas, S., & Miller, Y. I. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049831 · Cited by 175
Chi, H., Messas, E., Levine, R. A., Graves, D. T., & Amar, S. (2004) · Circulation · doi:10.1161/01.cir.0000142085.39015.31 · Cited by 173
Schober, A., Bernhagen, J., Thiele, M., Zeiffer, U., Knarren, S., Roller, M., Bucala, R., & Weber, C. (2004) · Circulation · doi:10.1161/01.cir.0000109201.72441.09 · Cited by 171
Dinh, T. N., Kyaw, T. S., Kanellakis, P., To, K., Tipping, P., Toh, B.-H., Bobik, A., & Agrotis, A. (2012) · Circulation · doi:10.1161/circulationaha.112.099044 · Cited by 170
Potteaux, S., Esposito, B., van Oostrom, O., Brun, V., Ardouin, P., Groux, H., Tedgui, A., & Mallat, Z. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000134378.86443.cd · Cited by 169
Pan, J.-H., Sukhova, G. K., Yang, J.-T., Wang, B., Xie, T., Fu, H., Zhang, Y., Satoskar, A. R., David, J. R., Metz, C. N., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134704.84454.d2 · Cited by 169
Bonaterra, G. A., Zügel, S., Thogersen, J., Walter, S. A., Haberkorn, U., Strelau, J., & Kinscherf, R. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002550 · Cited by 169
Liu, P., Yu, Y.-R. A., Spencer, J. A., Johnson, A. E., Vallanat, C. T., Fong, A. M., Patterson, C., & Patel, D. D. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.158675 · Cited by 168
Butcher, M. J., Gjurich, B. N., Phillips, T., & Galkina, E. V. (2012) · Circulation Research · doi:10.1161/circresaha.111.261784 · Cited by 165
Isoda, K., Sawada, S., Ishigami, N., Matsuki, T., Miyazaki, K., Kusuhara, M., Iwakura, Y., & Ohsuzu, F. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000127025.48140.a3 · Cited by 164
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice
van Es, T., van Puijvelde, G. H. M., Ramos, O. H., Segers, F. M. E., Joosten, L. A., van den Berg, W. B., Michon, I. M., de Vos, P., van Berkel, T. J. C., & Kuiper, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.07.152 · Cited by 163
Secchiero, P., Candido, R., Corallini, F., Zacchigna, S., Toffoli, B., Rimondi, E., Fabris, B., Giacca, M., & Zauli, G. (2006) · Circulation · doi:10.1161/circulationaha.106.643841 · Cited by 163
Ishibashi, M., Egashira, K., Zhao, Q., Hiasa, K.-I., Ohtani, K., Ihara, Y., Charo, I. F., Kura, S., Tsuzuki, T., Takeshita, A., et al. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000143384.69170.2d · Cited by 162
Wolfs, I., Donners, M., & de Winther, M. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-05-0320 · Cited by 157
A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice
Braunersreuther, V., Steffens, S., Arnaud, C., Pelli, G., Burger, F., Proudfoot, A., & Mach, F. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.165423 · Cited by 156
King, V. L., Cassis, L. A., & Daugherty, A. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060857 · Cited by 155
Cipriani, S., Francisci, D., Mencarelli, A., Renga, B., Schiaroli, E., D’Amore, C., Baldelli, F., & Fiorucci, S. (2013) · Circulation · doi:10.1161/circulationaha.113.001278 · Cited by 154
Therapeutic targeting of chemokine interactions in atherosclerosis
Koenen, R. R., & Weber, C. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3048 · Cited by 153
Erbel, C., Akhavanpoor, M., Okuyucu, D., Wangler, S., Dietz, A., Zhao, L., Stellos, K., Little, K. M., Lasitschka, F., Doesch, A., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400181 · Cited by 151
Zernecke, A., Liehn, E. A., Gao, J.-L., Kuziel, W. A., Murphy, P. M., & Weber, C. (2006) · Blood · doi:10.1182/blood-2005-09-3922 · Cited by 148
Veillard, N. R., Steffens, S., Pelli, G., Lu, B., Kwak, B. R., Gerard, C., Charo, I. F., & Mach, F. (2005) · Circulation · doi:10.1161/circulationaha.104.520718 · Cited by 148
Turrentine, T., Dawicki McKenna, J., Rux, A., Rader, D., Kowalska, A., & Sachais, B. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-04-0271 · Cited by 147
Devlin, C. M., Kuriakose, G., Hirsch, E., & Tabas, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092324399 · Cited by 147
Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice
Albers, J., Rajski, M., Schönenberger, D., Harlander, S., Schraml, P., von Teichman, A., Georgiev, S., Wild, P. J., Moch, H., Krek, W., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202231 · Cited by 147
Gojova, A., Brun, V., Esposito, B., Cottrez, F., Gourdy, P., Ardouin, P., Tedgui, A., Mallat, Z., & Groux, H. (2003) · Blood · doi:10.1182/blood-2003-05-1729 · Cited by 146
Burger‐Kentischer, A., Göbel, H., Kleemann, R., Zernecke, A., Bucala, R., Leng, L., Finkelmeier, D., Geiger, G., Schaefer, H. E., Schober, A., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.028 · Cited by 144
Interleukin‐10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
Han, X., Kitamoto, S., Wang, H., & Boisvert, W. A. (2010) · The FASEB Journal · doi:10.1096/fj.09-148155 · Cited by 143
Johnson, J. L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu171 · Cited by 138
Galkina, E., Harry, B. L., Ludwig, A., Liehn, E. A., Sanders, J. M., Bruce, A. C., Weber, C., & Ley, K. F. (2007) · Circulation · doi:10.1161/circulationaha.106.678474 · Cited by 136
The role of transforming growth factor-β in atherosclerosis
SINGH, N., & Ramji, D. P. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.09.002 · Cited by 132
Self-citationPanousis, C. G., & Zuckerman, S. H. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1565 · Cited by 131
Tenger, C., Sundborger, A., Jawien, J., & Zhou, X. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000153516.02782.65 · Cited by 130
Expression of Tumor Necrosis Factor Receptor-1 in Arterial Wall Cells Promotes Atherosclerosis
Zhang, L., Peppel, K., Sivashanmugam, P., Orman, E. S., Brian, L., Exum, S. T., & Freedman, N. J. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000261548.49790.63 · Cited by 127
Krohn, R. M., Raffetseder, U., Bot, I., Zernecke, A., Shagdarsuren, E., Liehn, E. A., van Santbrink, P. J., Nelson, P. J., Biessen, E. A. L., Mertens, P. R., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.708016 · Cited by 125
van Wanrooij, E. J. A., de Jager, S. C. A., van Es, T., de Vos, P., Birch, H. L., Owen, D. A., Watson, R. J., Biessen, E. A. L., Chapman, G. A., van Berkel, T. J. C., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147827 · Cited by 121
Chen, S., Shimada, K., Zhang, W., Huang, G., Crother, T. R., & Arditi, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001879 · Cited by 119
Kamari, Y., Shaish, A., Shemesh, S. S., Vax, E., Grosskopf, I., Dotan, S., White, M. R., Voronov, E., Dinarello, C. A., Apte, R. N., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.008 · Cited by 118
Mechanoresponsive Networks Controlling Vascular Inflammation
Bryan, M. T., Duckles, H., Feng, S., Hsiao, S. T.-F., Kim, H. R., Serbanovic‐Canic, J., & Evans, P. C. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303424 · Cited by 118
Bartolo, B. A. D., Chan, J., Bennett, M. R., Cartland, S. P., Bao, S., Tuch, B. E., & Kavurma, M. M. (2011) · Diabetologia · doi:10.1007/s00125-011-2308-0 · Cited by 117
Ruan, X. Z., Moorhead, J. F., Tao, J. L., Ma, K. L., Wheeler, D. C., Powis, S. H., & Varghese, Z. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000217957.93135.c2 · Cited by 116
Potteaux, S., Combadière, C., Esposito, B., Lecureuil, C., Ait-Oufella, H., Merval, R., Ardouin, P., Tedgui, A., & Mallat, Z. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000231527.22762.71 · Cited by 116
Tumor necrosis factor-? promotes atherosclerotic lesion progression in APOE*3-leiden transgenic mice
BOESTEN, L., ZADELAAR, A., VANNIEUWKOOP, A., GIJBELS, M., DEWINTHER, M., HAVEKES, L., & VANVLIJMEN, B. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.001 · Cited by 116
Interleukin-1 Regulates Multiple Atherogenic Mechanisms in Response to Fat Feeding
Chamberlain, J., Francis, S., Brookes, Z., Shaw, G., Graham, D., Alp, N. J., Dower, S., & Crossman, D. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005073 · Cited by 114
CXCL5 limits macrophage foam cell formation in atherosclerosis
Rousselle, A., Qadri, F., Leukel, L., Yılmaz, R., Fontaine, J., Sihn, G., Bäder, M., Ahluwalia, A., & Duchêne, J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66580 · Cited by 114
Frisdal, E., Lesnik, P., Olivier, M., Robillard, P., Chapman, M. J., Huby, T., Guerin, M., & Le Goff, W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.264325 · Cited by 113
Kruithof, E. K. O. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-04-0269 · Cited by 112
Deficiency of Interleukin-1 Receptor Antagonist Promotes Neointimal Formation After Injury
Isoda, K., Shiigai, M., Ishigami, N., Matsuki, T., Horai, R., Nishikawa, K., Kusuhara, M., Nishida, Y., Iwakura, Y., & Ohsuzu, F. (2003) · Circulation · doi:10.1161/01.cir.0000085567.18648.21 · Cited by 107
Canault, M., Peiretti, F., Mueller, C., Kopp, F., Morange, P., Rihs, S., Portugal, H., Juhan-Vague, I., & Nalbone, G. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.10.004 · Cited by 107
McPhillips, K., Janssen, W. J., Ghosh, M., Byrne, A., Gardai, S., Remigio, L., Bratton, D. L., Kang, J. L., & Henson, P. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8117 · Cited by 106
Buckley, M. L., & Ramji, D. P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.04.011 · Cited by 106
Self-citationHaghighat, A., Weiss, D., Whalin, M. K., Cowan, D. P., & Taylor, W. R. (2007) · Circulation · doi:10.1161/circulationaha.106.665570 · Cited by 106
Pharmacological Inhibition of the Chemokine Receptor, CX3CR1, Reduces Atherosclerosis in Mice
Poupel, L., Boissonnas, A., Hermand, P., Dorgham, K., Guyon, E., Auvynet, C., Saint-Charles, F., Lesnik, P., Déterre, P., & Combadière, C. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300930 · Cited by 102
Frutkin, A. D., Otsuka, G., Stempien-Otero, A., Sesti, C., Du, L., Jaffe, M., Dichek, H. L., Pennington, C. J., Edwards, D. R., Nieves-Cintrón, M., et al. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186593 · Cited by 100
Wågsäter, D., Olofsson, P. S., Norgren, L., Stenberg, B., & Sirsjö, A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.160 · Cited by 99
Christen, S., Thomas, S. R., Garner, B., & Stocker, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117211 · Cited by 97
Akhtar, S., Gremse, F., Kiessling, F. M., Weber, C., & Schober, A. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301162 · Cited by 96
Chen, W., Cheng, B., Jiang, M. J., Hsieh, M., & Chang, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000232502.88144.6f · Cited by 96
Evidence for a Role of Macrophage Migration Inhibitory Factor in Vascular Disease
Chen, Z., Sakuma, M., Zago, A. C., Zhang, X., Shi, C., Leng, L., Mizue, Y., Bucala, R., & Simon, D. I. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000119356.35748.9e · Cited by 94
Madan, M., Bishayi, B., Hoge, M., & Amar, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.02.023 · Cited by 93
Li, N., McLaren, J. E., Michael, D. R., Clement, M., Fielding, C. A., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000993 · Cited by 93
Self-citationJohnen, H., Kuffner, T., Brown, D. A., Wu, B. J., Stocker, R., & Breit, S. N. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.02.003 · Cited by 91
Subramanian, M., Thorp, E., & Tabas, I. (2015) · Circulation Research · doi:10.1161/circresaha.116.304794 · Cited by 90
The TNF-Like Protein 1A–Death Receptor 3 Pathway Promotes Macrophage Foam Cell Formation In Vitro
McLaren, J. E., Calder, C. J., McSharry, B. P., Sexton, K., Salter, R. C., Singh, N. N., Wilkinson, G. W. G., Wang, E. C. Y., & Ramji, D. P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903782 · Cited by 89
Self-citationChemokine Receptor 7 Knockout Attenuates Atherosclerotic Plaque Development
Luchtefeld, M., Grothusen, C., Gagalick, A., Jagavelu, K., Schuett, H., Tietge, U. J. F., Pabst, O., Grote, K., Drexler, H., Förster, R., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.956730 · Cited by 88
Shaposhnik, Z., Wang, X., Weinstein, M., Bennett, B. J., & Lusis, A. J. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000254673.55431.e6 · Cited by 87
Koga, M., Kai, H., Yasukawa, H., Yamamoto, T., Kawai, Y., Kato, S., Kusaba, K., Kai, M., Egashira, K., Kataoka, Y., et al. (2007) · Circulation Research · doi:10.1161/circresaha.106.147256 · Cited by 86
Panousis, C. G., Evans, G. F., & Zuckerman, S. H. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31648-5 · Cited by 85
CC chemokine receptor 5 influences late-stage atherosclerosis
Quinones, M. P., Martinez, H. G., Jiménez, F., Estrada, C. A., Dudley, M., Willmon, O., Kulkarni, H. R., Reddick, R. L., Fernandes, G., Kuziel, W. A., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.026 · Cited by 82
Smooth muscle cell phenotypic switch: implications for foam cell formation
Chaabane, C., Coen, M., & Bochaton-Piallat, M.-L. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000113 · Cited by 82
Liehn, E. A., Schober, A., & Weber, C. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000143135.71440.75 · Cited by 82
Liu, Y., Li, D., Chen, J., Xie, J., Bandyopadhyay, S., Zhang, D., Nemarkommula, A. R., Liu, H., Mehta, J. L., & Hermonat, P. L. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.029 · Cited by 81
de Villiers, W. J. S., Smith, J. D., Miyata, M., Dansky, H. M., Darley, E., & Gordon, S. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.4.631 · Cited by 81
Cytokine Modulation of LDL Oxidation by Activated Human Monocytes
Folcik, V. A., Aamir, R., & Cathcart, M. K. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1954 · Cited by 79
de Jager, S. C. A., Bot, I., Kraaijeveld, A. O., Korporaal, S. J. A., Bot, M., van Santbrink, P. J., van Berkel, T. J. C., Kuiper, J., & Biessen, E. A. L. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300857 · Cited by 79
Yoshioka, T., Okada, T., Maeda, Y., Ikeda, U., Shimpo, M., Nomoto, T., Takeuchi, K., Nonaka‐Sarukawa, M., Ito, T., Takahashi, M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302348 · Cited by 79
Ditiatkovski, M., Toh, B.-H., & Bobik, A. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000238357.60338.90 · Cited by 79
Gisterå, A., Robertson, A.-K., Andersson, J., Ketelhuth, D. F. J., Овчинникова, О. А., Nilsson, S. K., Lundberg, A. M., Li, M. O., Flavell, R. A., & Hansson, G. K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.05.233 · Cited by 78
Lievens, D., Habets, K. L. L., Robertson, A.-K., Laouar, Y., Winkels, H., Rademakers, T., Beckers, L., Wijnands, E., Boon, L., Mosaheb, M. M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs106 · Cited by 76
GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis
Preusch, M. R., Baeuerle, M., Albrecht, C., Blessing, E., Bischof, M., Katus, H. A., & Bea, F. (2013) · European journal of medical research · doi:10.1186/2047-783x-18-19 · Cited by 75
Macrophage proliferation and apoptosis in atherosclerosis
Andrés, V., Pello, O. M., & Silvestre-Roig, C. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328357a379 · Cited by 74 · cited 1×
“For instance, some, such as IFN-g, TNF-a and IL-1b, promote apoptosis of macrophages along with foam cells leading to enlargement of the lipid core [231].”
BackgroundCXCR4 blockade induces atherosclerosis by affecting neutrophil function
Bot, I., Daissormont, I., Zernecke, A., van Puijvelde, G. H. M., Kramp, B. K., de Jager, S. C. A., Sluimer, J. C., Manca, M., Hérias, V., Westra, M. M., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.04.021 · Cited by 74
Bursill, C. A., Choudhury, R. P., Ali, Z. A., Greaves, D. R., & Channon, K. M. (2004) · Circulation · doi:10.1161/01.cir.0000145122.58420.co · Cited by 74
Interleukin 27 inhibits atherosclerosis via immunoregulation of macrophages in mice
Hirase, T., Hara, H., Miyazaki, Y., Ide, N., Nishimoto-Hazuku, A., Fujimoto, H., Saris, C. J. M., Yoshida, H., & Node, K. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00198.2013 · Cited by 73
Guo, J., Eck, M. V., Twisk, J., Maeda, N., Benson, G. M., Groot, P. H. E., & van Berkel, T. J. C. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000058431.78833.f5 · Cited by 72
Xanthoulea, S., Thelen, M., Pöttgens, C. C. H., Gijbels, M. J., Lutgens, E., & de Winther, M. P. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006113 · Cited by 72
Wang, M., Subramanian, M., Abramowicz, S., Murphy, A. J., Gonen, A., Witztum, J., Welch, C., Tabas, I., Westerterp, M., & Tall, A. R. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.303097 · Cited by 70
Interleukin-27 Receptor Limits Atherosclerosis in Ldlr −/− Mice
Koltsova, E. K., Kim, G., Lloyd, K. M., Saris, C. J. M., von Vietinghoff, S., Kronenberg, M., & Ley, K. F. (2012) · Circulation Research · doi:10.1161/circresaha.112.277525 · Cited by 70
Interleukin-18-induced atherosclerosis involves CD36 and NF-κB crosstalk in Apo E−/− mice
Bhat, O. M., Kumar, P., Giridharan, N. V., Kaul, D., Kumar, M., & Dhawan, V. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.10.012 · Cited by 69
Noels, H., Zhou, B., Tilstam, P. V., Theelen, W., Li, X., Pawig, L., Schmitz, C., Akhtar, S., Simsekyilmaz, S., Shagdarsuren, E., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.302878 · Cited by 68
Cellular and molecular players in the atherosclerotic plaque progression
Businaro, R., Tagliani, A., Buttari, B., Profumo, E., Ippoliti, F., Cristofano, C. D., Capoano, R., Salvati, B., & Riganò, R. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06600.x · Cited by 66
TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
Bartolo, B. A. D., Cartland, S. P., Harith, H. H., Bobryshev, Y. V., Schoppet, M., & Kavurma, M. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074211 · Cited by 66
Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-γ
Panousis, C. G., & Zuckerman, S. H. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32076-9 · Cited by 65
Li, X., Zhu, M., Penfold, M. E., Koenen, R. R., Thiemann, A., Heyll, K., Akhtar, S., Koyadan, S., Wu, Z., Gremse, F., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.006840 · Cited by 64
Atherosclerotic Plaque Stability Is Affected by the Chemokine CXCL10 in Both Mice and Humans
Segers, D., Lipton, J. A., Leenen, P. J. M., Cheng, C., Tempel, D., Pasterkamp, G., Moll, F. L., de Crom, R., & Krams, R. (2011) · International Journal of Inflammation · doi:10.4061/2011/936109 · Cited by 64
Human tissue-type plasminogen activator
Kruithof, E. K. O., & Dunoyer-Geindre, S. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0517 · Cited by 63
Nie, P., Li, D., Hu, L., Jin, S., Yu, Y., Cai, Z., Shao, Q., Shen, J., Yi, J., Xiao, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097009 · Cited by 62
Döring, Y., Noels, H., Mandl, M., Kramp, B., Neideck, C., Lievens, D., Drechsler, M., Megens, R. T. A., Tilstam, P. V., Langer, M., et al. (2014) · Circulation Research · doi:10.1161/circresaha.114.302426 · Cited by 61
Mazière, C., Auclair, M., & Mazière, J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80113-4 · Cited by 60
Cited by
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“Cytokines are involved in all stages of the pathogenesis of atherosclerosis, having both pro- or anti-atherogenic effects (342, 343).”
BackgroundMCP-1: Function, regulation, and involvement in disease
Singh, S., Anshita, D., & Ravichandiran, V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107598 · Cited by 883
Inflammatory cytokines in atherosclerosis: current therapeutic approaches
Tousoulis, D., Oikonomou, E., Economou, E. K., Crea, F., & Kaski, J. C. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv759 · Cited by 460
ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders
Singh, V., Kaur, R., Kumari, P., Pasricha, C., & Singh, R. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117487 · Cited by 432
Zhu, X., Chen, Z., Shen, W., Huang, G., Sedivy, J. M., Wang, H., & Ju, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00646-9 · Cited by 393
Metadata
- Authors
- Ramji, D. P., & Davies, T. S.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 26
- Issue
- 6
- Pages
- 673-685
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W1840986526
- Cited by
- 469
- References
- 246
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.